Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
개정된 생물학적 동등성 시험 기준에 대한 통계적 고찰Statistical consideration of assessing bioequivalence in the new KFDA regulation
- Issue Date
- Mar-2002
- Publisher
- 한국통계학회
- Citation
- 응용통계연구, v.15, no.2, pp 7 - 296
- Pages
- 290
- Journal Title
- 응용통계연구
- Volume
- 15
- Number
- 2
- Start Page
- 7
- End Page
- 296
- ISSN
- 1225-066X
2383-5818
- Abstract
- On the new medical system separating the prescription and dispensing of the drug,the qualication of pharmacist in substitution of prescribed medicine was restricted, ex-cept bioequivalence-certied drugs. Also, Korean Fod and Drug Association(KFDA)revised the bioequivalence regulation on August, 2001. Among many changes fromold guideline, impressive one is the statistical consideration. Specially, to estimate andanalyze bioequivalence measures, AUC and Cmax , the log-transformed model is recom-mended and the equivalence interval is modied from 20 rule to [ln(0:8);ln(1:25)] one.This meaningful act is very hope-for because it is statistically reasonable and is agreedwith worldwide bioequivalence guideline, including USA, EU, Japan and Canada. In
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - The Office of Research Affairs > Affiliated Research Institute > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.